Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease
Introduction
Alzheimer's disease (AD), the most common cause of dementia in elderly patients, is a complex disorder of the central nervous system clinically characterized by a progressive loss of cognitive abilities. Pathological hallmarks of AD include widespread neuronal degeneration, neurite plaques containing β-amyloid (Aβ), and intracellular neurofibrillary tangles [24], [35]. The Aβ is the major component of senile plaques and is derived from the amyloid precursor protein (APP) by proteolytic cleavage [36]. Although accumulated evidence suggests that Aβ is a key causative agent of AD [11], [33], the exact mechanism of neuronal degeneration in AD has not been clear. It is likely that multiple factors are involved in the development of the disease.
Kanfer et al. [17] have suggested that neuronal degeneration in AD might be related to an alteration in tissue phospholipids with a corresponding increase in the catabolic products of phospholipids metabolism. Aβ is known to affect the activity of several lipid-metabolizing enzymes, including the phospholipases A2, C and D [16], [31], [32]. However, it is unknown whether these phospholipids alternations are sufficient and necessary for the etiology of AD or if they are secondary events in the pathogenesis of neurodegeneration. Recently, phospholipids breakdown by phospholipase D (PLD) has been recognized as an important signaling pathway in the nervous system.
PLD catalyzes the hydrolysis of phosphatidylcholine (PC), the major membrane phospholipid, to produce the pleiotropic signaling lipid messenger phosphatidic acid (PA). PA is generally recognized as the signaling product of PLD and functions as an effector in multiple physiological processes [21]. In mammals, two isoforms of PLD, PLD1 and PLD2, have been cloned and are being characterized for regulation and cellular function [21]. However, the segregated roles of the two PLD isoforms in cellular responses are still poorly understood. Activation of PLD occurs through interactions of the ARF and Rho families as well as with protein kinase C (PKC) [21]. Recently, we have reported that PLD1 immunoreactivity and its enzymatic activity were up-regulated in the activated astrocytes of scrapie-infected mice brain [14]. However, the expression of PLD in AD brains has not been investigated so far.
These studies have raised the possibility that PLD might be involved in the neuronal pathology associated with AD. In the present study, we demonstrate for the first time that PLD1 is up-regulated in the caveolae membrane fraction and reactive astrocytes from AD brains, and co-localized and associated with APP.
Section snippets
Brain tissues
A total of six post-mortem brain specimens of Alzheimer's disease patients and age-matched controls were obtained from the IBR brain bank (Dr. Piotr B. Kozlowski). The characteristics of the brain specimens with post-mortem intervals ranging from 0.5 to 14.5 h are shown in Table 1. Cases of Alzheimer's disease and age-matched controls were classified based on quantitative pathological features including senile plaques and neurofibrillary tangles (NFT) according to Braak and Braak [1].
Cell culture and transfections
COS-7 cells
PLD1 is up-regulated in reactive astrocytes of the brains of AD patients
To investigate the possibility that PLD expression is altered in AD brain tissues, we immunostained AD brain sections from patients using anti-PLD antibody. We observed enhanced PLD immunoreactivity in the brains of AD patients compared to that of elderly controls (Fig. 1A and B). Barely detectable levels were found in normal human hippocampus section (Fig. 1A). We detected strong PLD immunoreactivity in the hippocampal sections from AD patients via DAB staining (Fig. 1B). The cells that
Discussion
The major findings of this report are that PLD1 is significantly up-regulated in brain tissues from AD patients relative to age-matched control subjects, and that PLD1 binds to APP. PLD1 was heavily accumulated in reactive astrocytes and co-localized with APP and caveolin-3 in the brains of patients with AD. In the present study, we found that the expression of PLD1 is markedly increased in caveolin-enriched fraction from AD brains. Recently, we have reported that the expression of PLD1 in
Acknowledgements
This study was supported by grant No. R01-2006-000-10521-0 (2006) from the Basic Research Program of the Korea Science & Engineering Foundation and by the Biotechnology Development Program (grant number 2005-00115) from Ministry of Science and Technology (MOST), Korea and grant of the Korea Health 21 R&D project, Ministry of Health and Welfare, Republic of Korea (A020007). A total of six post-mortem brain specimens of Alzheimer's disease patients and age-matched controls were obtained from the
References (39)
- et al.
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity
Cell
(1993) - et al.
Phospholipase D structure and regulation
Chem Phys Lipids
(1999) - et al.
Increased caveolin-1 expression in Alzheimer's disease brain
Neurobiol Aging
(2004) - et al.
Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein
J Biol Chem
(1998) - et al.
Upregulation of phospholipase D1 in the spinal cords of rats with clip compression injury
Neurosci Lett
(2003) - et al.
Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell
J Lipid Mediat Cell Signal
(1996) - et al.
Phospholipases as mediators of amyloid beta peptide neurotoxicity: an early event contributing to neurodegeneration characteristic of Alzheimer's disease
Neurosci Lett
(1998) - et al.
Receptor-activated phospholipase D is present in caveolin-3-enriched light membranes of C2C12 myotubes
FEBS Lett
(2000) - et al.
Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells
Neuropharmacology
(2001) - et al.
Alzheimer's disease-do tauists and baptists finally shake hands?
Trends Neurosci
(2002)
Activation of phospholipase D and the possible mechanism of activation in wound-induced lipid hydrolysis in castor bean leaves
Biochim Biophys Acta
Amyloid beta protein (25–35) stimulation of phospholipases A, C and D activities of LA-N-2 cells
FEBS Lett
Alzheimer's disease and the amyloid cascade hypothesis: 10 years on
Curr Opin Pharmacol
Intraneuronal beta-amyloid immunoreactivity in the CNS
Neurobiol Aging
Abeta-generating enzymes: recent advances in beta- and gamma-secretase research
Neuron
Changes in lipid composition of cortical synaptosomes from different age groups of mice
Life Sci
Neuropathological stageing of Alzheimer-related changes
Acta Neuropathol
Presenilin-1 uses phospholipase D1 as a negative regulator of b-amyloid formation
Proc Natl Acad Sci USA
Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons
Proc Natl Acad Sci USA
Cited by (37)
Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy
2022, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCanonical phospholipase D isoforms in visual function and ocular response to stress
2022, Experimental Eye ResearchFrom beta amyloid to altered proteostasis in Alzheimer's disease
2020, Ageing Research ReviewsMammalian phospholipase D: Function, and therapeutics
2020, Progress in Lipid ResearchCitation Excerpt :PLD activity was increased by APP in P19 mouse embryonic carcinoma cells [534] and oligomeric Aβ in cultured neurons [39]. PLD is also implicated in regulation of APP trafficking, as well as trafficking of presenilin-1 (PS1), a component of the γ-secretase which mediates APP cleavage to generate Aβ [36–41,188,528,535–539]. Both the PLD1 and PLD2 isoforms are linked to AD [37,39,188].
Elevated phospholipase D isoform 1 in Alzheimer's disease patients’ hippocampus: Relevance to synaptic dysfunction and memory deficits
2018, Alzheimer's and Dementia: Translational Research and Clinical InterventionsCitation Excerpt :Previous studies proposed a neuroprotective role for PLD1 where a direct effect of overexpressed PLD1 on presenilin-1 results in reduction of Aβ species generation [16], by promoting trans-Golgi intracellular trafficking of β APP and promoting neurite outgrowth [17]. Perhaps, the elevated PLD1 levels in the activated astrocytes and mitochondrial fractions of AD brains, reported in another set of studies [18,36], could be explained as neuroprotective. However, the authors indicate that the amyloid region of APP interacts with PLD1 and increased APP expression stimulates PLD1 activity, thus questioning the speculated neuroprotective role of PLD1.
Phosphatidic acid-producing enzymes regulating the synaptic vesicle cycle: Role for PLD?
2018, Advances in Biological Regulation